Protalix Biotherapeutics, Inc.
(NYSE Amex Equities : PLX)

... ...
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Servicestothe Health Industry
DGXQuest Diagnostics, Inc. 0.84%126.024.2%$165.82m
LHLaboratory Corp. of America Holdings -1.57%221.902.4%$147.14m
IQVIQVIA Holdings, Inc. -1.46%180.340.0%$137.19m
SYNHSyneos Health, Inc. -3.10%75.440.0%$47.99m
AMEHApollo Medical Holdings, Inc. 1.39%22.550.0%$2.54m
BASIBioanalytical Systems, Inc. -3.44%13.490.2%$1.76m
NRCNational Research Corp. 0.31%48.120.0%$1.67m
PLXProtalix Biotherapeutics, Inc. 2.69%4.5825.3%$1.17m
IDXGInterpace Biosciences, Inc. 3.02%4.4322.7%$0.64m
PMDPsychemedics Corp. 34.30%7.440.7%$0.57m

Company Profile

Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel.